Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing.
On January 25, 2023, Advantage Solutions Inc. (the "Company") received a written
notification from The Nasdaq Stock Market LLC ("Nasdaq") regarding its
noncompliance with Nasdaq Listing Rule 5605(c)(2) ("Rule 5605"), which requires,
among other things, that the Audit Committee (the "Audit Committee") of the
Board of Directors of the Company (the "Board") be comprised of a minimum of
three independent directors. As previously disclosed on November 23, 2022,
Ronald Blaylock, one of the Company's directors, ceased serving on the Audit
Committee as of November 23, 2022, and as a result, the Company's Audit
Committee is currently comprised of only two independent directors resulting in
the noncompliance. In accordance with Nasdaq Listing Rule 5605(c)(4), the
Company is granted a cure period in order to regain compliance with Rule 5605
lasting until (a) the earlier of the Company's next annual stockholders' meeting
or November 23, 2023, or (b) if the next annual stockholders' meeting is held
before May 22, 2023, May 22, 2023. The Company intends to appoint a third
independent director to the Audit Committee, and thereby regain compliance with
Rule 5605, prior to the end of the cure period.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
ADVANTAGE SOLUTIONS INC. 
